Said Taharboucht,Asma Azoug,El Djouher Saidoun et al.
Said Taharboucht et al.
Tuberculosis, though infrequently involved, may coexist with giant cell arteritis (GCA), sharing similar clinical features that complicate diagnosis. Their association is exceptionally rare, presenting a significant diagnostic challenge for clinicians....Keywords: aortitis; giant cell arteritis; giant cell arteritis – tuberculosis coexistence; immunosupressive drugs; large vessel vasculitis; rare association; systemic inflammation; temporal artery biopsy; tuberculosis; vasculitis.
Case Reports
Cureus. 2025 Nov 2;17(11):e95972. DOI:10.7759/cureus.95972 2025
Fast-track pathway for giant cell arteritis: Improved visual outcomes and reduced healthcare costs [0.03%]
giant cell arteritis快速通道途径：改善视觉效果和减少医疗保健费用
Loïc Duron,Thibaud Chazal,Thomas Sene et al.
Loïc Duron et al.
We assessed the impact of a fast-track pathway (FTP) for early diagnosis and treatment of giant cell arteritis in terms of hospitalization patterns and cost-effectiveness.
Large Vessel Vasculitis: Multimodality Imaging Findings and Technical Principles [0.03%]
大血管炎的多模态影像检查及技术原理
Mitesh Naik,Sophie J M Canham,Luke Dixon et al.
Mitesh Naik et al.
Large vessel vasculitis (LVV) is divided into two main categories of giant cell arteritis (GCA) and Takayasu arteritis (TA).
Identification of BHLHE40-expressing T cells in giant cell arteritis amplified by interleukin-1 [0.03%]
IL-1诱导的BHLHE40表达T细胞在巨细胞动脉炎中的鉴定
Sho Ishigaki,Katsuya Suzuki,Kazuhiro Yamanoi et al.
Sho Ishigaki et al.
Peripheral blood (PB) from healthy controls (HCs) and patients with giant cell arteritis (GCA) was analyzed using flow cytometry to assess BHLHE40 expression across helper T cells.
Francesca Regola,Jacopo Mora,Matteo Riva et al.
Francesca Regola et al.
Objectives: Giant cell arteritis (GCA) therapy relies on high-dose glucocorticoids (GCs), which are associated with a high incidence of side effects and GCA relapses, highlighting the need for steroid-sparing agents such ...
Eosinophilic granulomatosis with polyangiitis mimicking giant cell arteritis [0.03%]
以巨细胞动脉炎样表现的嗜酸性肉芽肿伴聚动脉血管炎病變
Niv Levy,Heather McDonald,Edward A Margolin
Niv Levy
The effectiveness and safety of leflunomide in the treatment of giant cell arteritis: a systematic review and meta-analysis [0.03%]
来氟米特治疗巨细胞动脉炎的有效性和安全性：系统评价和 Meta 分析
Linda M Zhu,Arielle Mendel,Carolyn Ross et al.
Linda M Zhu et al.
Objectives: The objective of this systematic review is to assess the effectiveness and safety of leflunomide in the treatment of new-onset refractory or relapsing giant cell arteritis (GCA) as a glucocorticoid (GC)-sparing agent.
Unusual Presentation of Giant Cell Arteritis With Localised Temporal Artery Aneurysm [0.03%]
巨细胞动脉炎合并颞动脉瘤的罕见表现形式
Syed A Ahmad,Niazi Khairi,Meeran Hussain et al.
Syed A Ahmad et al.
Keywords: colored flow doppler ultrasound; fdg pet/ct scan; giant cell arteritis (gca); temporal aortic aneurysm; temporal artertitis; vasculitis. Copyright © 2025, Ahmad et al.
Case Reports
Cureus. 2025 Oct 28;17(10):e95624. DOI:10.7759/cureus.95624 2025
A Rare Case of Giant Cell Arteritis Affecting Two Giants: Pulmonary and Root of Aorta Aneurysm [0.03%]
巨大细胞动脉炎影响两大巨人的罕见病例：肺部和主动脉根部的动脉瘤
Gajendra Acharya,Hafiza Baloch,Pradeep Masuta et al.
Gajendra Acharya et al.
Despite normal inflammatory markers and no typical giant cell arteritis (GCA) symptoms, histopathology following surgical repair revealed focal GCA as the underlying cause.
Identification of therapeutic targets for giant cell arteritis through integrated analysis of multi-omics datasets [0.03%]
通过多组学数据集的综合分析鉴定巨细胞动脉炎的治疗靶点
Bi-Qing Huang,Yi-Xiao Tian,Lan-Juan Li
Bi-Qing Huang
Background: Giant cell arteritis (GCA), the most common systemic vasculitis affecting elderly individuals, currently lacks specific therapies. This study aimed to systematically identify therapeutic targets for GCA throug...
耗时 0.15186 秒，为您在
49055432
条记录里面共找到 5664 篇文章 [XML]